Reported Feb 10, 2021 · Terminated
Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel…
Taro Pharmaceuticals U.S.A., Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Taro Pharmaceuticals U.S.A., Inc. · 3 Skyline Dr · Hawthorne, NY · 10532-2174
Is this the product you have?
- Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd
- byTaro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist
- byTaro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532 NDC 51672-4001-1
- Lot codes and dates
AC05096AC05098and AC05099Exp 10/31/2022
- Amount recalled
- 44,256 bottles
Where it was sold
- Nationwide
Why it was recalled
CGMP deviations.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Taro Pharmaceuticals U.S.A., Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.